US FDA’s Cavazzoni Says Retaining Virtual Meetings Could Improve Communications Going Forward
One of the lessons learned from the pandemic may be that virtual meetings can be used in place of an in-person session more often.
You may also be interested in...
Stakeholders believe virtual meetings should remain an option going forward, but that in-person sessions should still be convened in many cases.
Patrizia Cavazzoni, FDA Center for Drug Evaluation and Research director, knows she has ‘huge shoes’ to fill. Convincing the CDER staff that she is capable of doing so is job one.
Patrizia Cavazzoni, the new director of the US FDA Center for Drug Evaluation & Research, knows that the has ‘huge shoes’ to fill. Convincing the CDER staff that she is capable of doing so is job one.